Figure 1.

Cumulative all-cause mortality standardized^a to total study sample by years from therapy initiation, race/ethnicity and sex, 10 017 human immunodeficiency virus-infected adults, 1998–2011. ^aStandardized by baseline covariates: age at therapy initiation, CD4 count and viral load, all modeled with restricted quadratic splines (with 4 knots located at the 5th, 35th, 65th and 95th percentiles), antiretroviral therapy naivety, prior diagnosis of any AIDS-defining condition at therapy initiation, injection drug use, and history of hepatitis C virus infection. Abbreviation: AA, African-American.